Mark J. Vignola, Chief Financial Officer at Terns Pharmaceuticals, Inc. (TERN), bought 743 shares at $3.78 ($3K) on 2023-11-30, disclosed to the SEC on 2023-12-04.
Open-market purchase of $3k TERN by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| TERN | BUY | 2024-06-04 | $21K | — | Filing → |
| TERN | BUY | 2023-06-02 | $14K | — | Filing → |
| TERN | BUY | 2023-02-03 | $4 | — | Filing → |